Diagnostic and prognostic biomarkers in head and neck squamous cell carcinoma;Tumormarker und Prognosefaktoren bei Plattenepithelkarzinomen der Kopf-Hals-Region

HNO

Volumn 58, Issue 7, 2010, Pages 713-725

  Lehnerdt, G ^a   Hoffmann, T K ^a   Mattheis, S ^a   Brandau, S ^a   Zeidler, R ^b   Lang, S ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Biomarker; Head and neck carcinoma; HNSCC; Prognosis; Tumormarker

Indexed keywords

TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; BLOOD; HEAD AND NECK TUMOR; HUMAN; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM PROTEINS; NEOPLASMS, SQUAMOUS CELL; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77954427587     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00106-010-2108-8     Document Type: Article

References (22)

1. Bagnardi V, Blangiardo M, La VC, Corrao G (2001) A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 85: 1700-1705.
2. Begum S, Gillison ML, Ansari-Lari MA et al (2003) Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res 9: 6469-6475.
3. Bonner JA, Harari PM, Giralt J et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354: 567-578.
4. Chang SS, Califano J (2008) Current status of biomarkers in head and neck cancer. J Surg Oncol 97: 640-643.
5. Chung CH, Parker JS, Karaca G et al (2004) Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5: 489-500.
6. Cojocariu OM, Huguet F, Lefevre M, Perie S (2009) Prognosis and predictive factors in head-and-neck cancers. Bull Cancer 96: 369-378.
7. Fakhry C, Westra WH, Li S et al (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100: 261-269.
8. Geisler SA, Olshan AF, Weissler MC et al (2002) p16 and p53 Protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer. Clin Cancer Res 8: 3445-3453.
9. Hoffmann TK, Whiteside TL, Bier H (2005) Plattenepithelkarzinome des Kopf-Hals-Bereichs - Grundlagen und aktuelle Konzepte der Immuntherapie. HNO 53: 285-298.
10. Hsu KF, Hung CF, Cheng WF et al (2001) Enhancement of suicidal DNA vaccine potency by linking mycobacterium tuberculosis heat shock protein 70 to an antigen. Gene Ther 8: 376-383.
11. Kornberg LJ, Villaret D, Popp M et al (2005) Gene expression profiling in squamous cell carcinoma of the oral cavity shows abnormalities in several signaling pathways. Laryngoscope 115: 690-698.
12. Lang S, Zeidler R (2003) Immune restoration in head and neck cancer patients via cyclooxygenase inhibition: an update. Int J Immunopathol Pharmacol 16: 41-48.
13. Langendijk JA, Slotman BJ, van der Waal I et al (2005) Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Cancer 104: 1408-1417.
14. Lehnerdt GF, Franz P, Zaqoul A et al (2008) Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene. Clin Cancer Res 14: 1753-1758.
15. Pai SI, Westra WH (2009) Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol 4: 49-70.
16. Pelucchi C, Gallus S, Garavello W et al (2008) Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver. Eur J Cancer Prev 17: 340-344.
17. Poeta ML, Manola J, Goldwasser MA et al (2007) TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med 357: 2552-2561.
18. Ranelletti FO, Almadori G, Rocca B et al (2001) Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma. Int J Cancer 95: 343-349.
19. Rocco JW, Li D, Liggett WH Jr et al (1998) p16INK4A adenovirus-mediated gene therapy for human head and neck squamous cell cancer. Clin Cancer Res 4: 1697-1704.
20. Scurry WC Jr, Stack BC Jr (2007) Role of metalloproteins in the clinical management of head and neck squamous cell carcinoma. Head Neck 29: 1144-1155.
21. Silva P, Homer JJ, Slevin NJ et al (2007) Clinical and biological factors affecting response to radiotherapy in patients with head and neck cancer: a review. Clin Otolaryngol 32: 337-345.
22. Thomas GR, Nadiminti H, Regalado J (2005) Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int J Exp Pathol 86: 347-363.